Vaxcyte News

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

16:07 ET

Vaxcyte | 8-K: Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

May 8 17:29 ET

Vaxcyte | 10-Q: Quarterly report

May 8 16:19 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim

May 3 16:26 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail

May 3 16:26 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer PICKERING GRANT

May 3 16:25 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

May 1 16:08 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

May 1 16:07 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

May 1 16:03 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer PICKERING GRANT

Apr 25 16:56 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 23 16:12 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer GUGGENHIME ANDREW

Apr 22 16:47 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim

Apr 19 16:36 ET

Vaxcyte | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 18 16:10 ET

Vaxcyte | ARS: Annual Report to Security Holders

Apr 15 16:35 ET

Vaxcyte | DEF 14A: Definitive information statements

Apr 15 16:11 ET

Vaxcyte | DEFA14A: Others

Apr 15 16:10 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Wassil Jim

Apr 3 16:28 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer Eydelman Mikhail

Apr 3 16:27 ET

Vaxcyte | 4: Statement of changes in beneficial ownership of securities-Officer PICKERING GRANT

Apr 3 16:26 ET